STOP: Diagnostic Overclaiming From Discovery Phase Microbiome Data (Pancreatic Cancer)
<!— STUB: needs expansion —>
Overview
STOP: Diagnostic Overclaiming from Discovery-Phase Microbiome Data (Pancreatic Cancer)
References (4)
Yixuan Meng, Feng Wu, Soyoung Kwak et al. (2025). Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer. JAMA Oncology. doi:10.1001/jamaoncol.2025.3377
Neil Daniel, Riccardo Farinella, Anastasia Chrysovalantou Chatziioannou et al. (2024). Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study. Scientific Reports. doi:10.1038/s41598-024-77431-5
Zhichen Jiang, Yiping Mou, Huiju Wang et al. (2023). Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. BMC Cancer. doi:10.1186/s12885-023-11493-y
Ailin Wei, Huiling Zhao, Xue Cong et al. (2022). Oral mycobiota and pancreatic ductal adenocarcinoma. BMC Cancer. doi:10.1186/s12885-022-10329-5